Roche is lining up a new wave of potential hit medicines across obesity, cancer, and multiple sclerosis, with many important trial results expected soon. The big question is whether these programs succeed before tougher competition and upcoming patent expiries start to bite.Read more

A new push from Washington to speed up approvals for big data-centre builds could land right in IREN’s lap, since it’s already lining up large sites in Texas powered by renewable energy. The big question is whether it can execute fast enough to justify today’s high expectations as it shifts from bitcoin mining toward selling computing power for AI.Read more

Micron is leaning into the boom in chips used for artificial intelligence, with a newer product line that could make its business less tied to the usual ups and downs of consumer gadgets. But the same cycle that can lift prices can also slam them, and the fight with bigger rivals plus rising U.S.–China tensions could quickly change the story.Read more

Why I Began Following This Company… My interest in Grab begins with the region it calls home. Southeast Asia is entering a transformative decade: young, fast-growing, and increasingly digital.Read more

Apple starts to look less like a company that wins by selling the next must-have gadget, and more like one that grows by keeping people inside its software and subscription ecosystem. That shift could make the business steadier, but it also raises a big question: can Apple compete in fast-moving areas like AI without losing its edge.Read more

Circle issues USDC, a digital version of the dollar that people use to move money and trade online, and new U.S. rules could make it easier for Circle to grow while some rivals stay on the sidelines. The catch is that Circle’s earnings can swing with interest rates and its close tie to Coinbase, so the upside comes with real bumps along the way.Read more

️Business Overview Total: 7/17 +1 ✅ Projected Operating Margin: 16.15% +1 ✅ Projected 5-Year Revenue CAGR: 10.89% +1 ✅ Last 5-Year ROIC: 10.00% +1 ✅ Estimated Cost of Capital: 9.26% (lower than ROIC) -1 ❌ Last 5-Year Shares Outstanding CAGR: +1.26% +1 ✅ Projected 5-Year EPS CAGR: 16.89% +0 ⚠️ Projected 5-Year Dividend CAGR: N/A +1 ✅ Moody's Debt Rating: A1 +2 ✅✅ Morningstar Moat: Wide +0 ⚠️ Morningstar Uncertainty: Medium Amazon transformed retail. Its solid operating margins (above ~10%) reflect more the other growing higher margin segments (cloud - AWS) rather than the lower margin business that is retail.Read more

Alphabet’s stock lags because many people worry that new chatbots could change how we search online and because regulators keep circling. But its huge reach across Search, YouTube, Android, and Gmail, plus growing cloud and creator tools, could make it one of the quieter long-term winners—if it executes and avoids a major hit to search.Read more

Hims & Hers is turning online care into a one-stop health subscription, combining testing, treatment, and follow-up so people can get help without dealing with insurance. The big upside comes from more personalized plans and new partnerships, but the company also faces real pushback from regulators and larger rivals.Read more